To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC47971 | Inonophenol C |
Inonophenol C is a neurotrophic and protective agent against neurodegenerative disorders.
More description
|
|
| DC47967 | KCNQ2/3 activator-1 |
KCNQ2/3 activator-1 is an activator of Kv7.2/Kv7.3 (KCNQ2/3) potassium channel. KCNQ2/3 activator-1 has the potential in relieving pain (the main problem from medical treatment) (extracted from patent WO2021113757A1, compound A).
More description
|
|
| DC47965 | KSPWFTTL |
KSPWFTTL is an immunodominant Kb-restricted epitope from the p15E transmembrane protein. KSPWFTTL can restore susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes.
More description
|
|
| DC47964 | KSPWFTTL TFA |
KSPWFTTL TFA is an immunodominant Kb-restricted epitope from the p15E transmembrane protein. KSPWFTTL TFA can restore susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes.
More description
|
|
| DC47958 | Lobelanine |
Lobelanine (8,10-Diphenyllobelidione) is a chemical precursor for the biosynthesis of Lobeline. Lobeline is a partial nicotinic agonist and is used as a smoking cessation agent.
More description
|
|
| DC47951 | MPO-IN-1 |
MPO-IN-1 is a potent, orally active, and irreversible indole-containing inhibitor of myeloperoxidase (MPO). MPO-IN-1 has IC50s of 2.6 μM and 5.3 μM for MPO and thyroid peroxidase (TPO), respectively. MPO-IN-1 inhibits MPO activity in an acute mouse model of inflammation.
More description
|
|
| DC47950 | MPO-IN-3 |
MPO-IN-3 is a potent myeloperoxidase (MPO) inhibitor (WO2013068875A1, example 191). Myeloperoxidase (MPO) is a heme-containing enzyme belonging to the peroxidase superfamily.
More description
|
|
| DC47949 | MrgprX2 antagonist-1 |
MrgprX2 antagonist-1 is an MrgprX2 antagonist extracted from patent WO2021092264A1, example E23. MrgprX2 antagonist-1 can be used for the research of inflammatory disorders of the skin.
More description
|
|
| DC47948 | MrgprX2 antagonist-2 |
MrgprX2 antagonist-2 is an MrgprX2 antagonist extracted from patent WO2021092262A1, example E163. MrgprX2 antagonist-2 can be used for the research of inflammatory disorders of the skin.
More description
|
|
| DC47947 | MrgprX2 antagonist-3 |
MrgprX2 antagonist-3 is an MrgprX2 antagonist extracted from patent WO2021092240A1, example E117. MrgprX2 antagonist-3 can be used for the research of inflammatory disorders of the skin.
More description
|
|
| DC47946 | MrgprX2 antagonist-4 |
MrgprX2 antagonist-4 is an MrgprX2 antagonist extracted from patent US20210128561A1, compound B-51 E117. MrgprX2 antagonist-4 can be used for the research of inflammatory disorders of the skin.
More description
|
|
| DC47945 | MrgprX2 antagonist-5 |
MrgprX2 antagonist-5 is an MrgprX2 antagonist extracted from patent WO2020223255A1, example 16. MrgprX2 antagonist-5 can be used for the research of inflammatory disorders of the skin.
More description
|
|
| DC47941 | Myrciaphenone A |
Myrciaphenone A is an acetophenone glucoside.
More description
|
|
| DC47934 | NSC639828 |
NSC639828 is a potent inhibitor of DNA polymerase with an IC50 of 70 μM. NSC639828 has high antitumor activity. NSC639828 has the potential for the treatment of cancer disease.
More description
|
|
| DC47933 | Onilcamotide |
Onilcamotide is a C-terminal peptide of RhoC protein. Onilcamotide is a cancer vaccine and has potential immunomodulating and antineoplastic activities.
More description
|
|
| DC47931 | OSBPL7-IN-1 |
OSBPL7-IN-1 is an orally active oxysterol binding protein like 7 (OSBPL7) inhibitor. OSBPL7-IN-1 promotes an increase of ABCA1 at the plasma membrane without affecting mRNA expression.
More description
|
|
| DC47929 | PA-9 |
PA-9 is a pituitary adenylate cyclase-activating polypeptide (PACAP) type I (PAC1) receptor antagonist. PA-9 dose dependently inhibits PACAP-induced cAMP elevation with an IC50 of 5.6 nM. PA-9 can be used for the research of neuropathic and/or inflammatory pain.
More description
|
|
| DC47926 | PCTR1 |
PCTR1 is a potent monocyte/macrophage agonist, regulating key anti-inflammatory and pro-resolving processes during bacterial infection. PCTR1 is a member of the protectin family of specialized pro-resolving mediators (SPMs).
More description
|
|
| DC47922 | PF-06445974 |
PF-06445974, a promising positron emission tomography (PET) lead, has exquisite potency at PDE4B with an IC50 <1 nM. The IC50 values are 36, 4.7 and 17 nM for PDE4D, PDE4A and PDE4C, respectively.
More description
|
|
| DC47919 | POBN |
POBN (4-POBN) is a cell permeable, hydrophilic spin trap that can be used to detect free radical adducts.
More description
|
|
| DC47904 | sEH inhibitor-1 |
sEH inhibitor-1 (compound TCPU ) is a potent and oral active inhibitor of sEH (soluble epoxide hydrolase) with IC50s of 0.4 and 5.3 nM in human and murine, respectively.
More description
|
|
| DC47892 | Streptavidin |
Streptavidin, a biotin-binding protein, is used as a versatile affinity tag. Streptavidin is used to visualize biotin conjugated molecule in a variety of biological applications, including Western blotting, Immunohistochemistry and ELISA.
More description
|
|
| DC47875 | Ulmoidol |
Ulmoidol prevents neuroinflammation by targeting the PU.1 transcriptional signaling pathway.
More description
|
|
| DC47867 | β-Damascone |
β-Damascone is an aroma active rice volatile and is widely used in perfume compositions. β-Damascone has also received certain attention as a potential cancer chemopreventive and a mosquito and muscoid insecticide.
More description
|
|
| DC22800 | ML-210 Featured |
A small-molecule probe that selectively kills cells induced to express mutant RAS.
More description
|
|
| DC22834 | Roseoflavin Featured |
Roseoflavin is a chemical analog of FMN and riboflavin that has antimicrobial activity.
More description
|
|
| DC22913 | WEB-2086 Featured |
A potent and specific antagonist of platelet activating factor (PAF) receptor that inhibits PAF-induced human platelet and neutrophil aggregation in vitro with IC50 of 0.17 and 0.36 uM, respectively.
More description
|
|
| DC22989 | BMS-204493 Featured |
A pan-RAR inverse agonist that blocks RARα activity with IC50 of 114 nM.
More description
|
|
| DC36924 | NNMTi Featured |
NNMTi is a nicotinamide N-methyltransferase (NNMT) inhibitor that promotes myoblast differentiation.
More description
|
|
| DC23191 | ZL-006 Featured |
ZL-006 (ZL 006, ZL006) is a brain penetrant small molecule inhibitor of PSD-95/nNOS interaction that prevents glutamate-induced excitotoxicity and cerebral ischemic damage in vivo.
More description
|
|